Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2018
Feeding the gut after revisional bariatric surgery: The fate of 126 enteral access tubes.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Strong Andrew T, Fayazzadeh Hana, Sharma Gautam, El-Hayek Kevin, Kroh Matthew, Rodriguez John
Аннотация
BACKGROUND: Revisional bariatric surgery (RBS) is associated with higher complication rates compared with primary bariatric surgery. Feeding tubes (FTs), including gastrostomy and jejunostomy tubes placed during RBS, may serve as a safety net to provide nutrition when oral intake is contraindicated or limited; however, FTs in this setting have not been well investigated.
OBJECTIVES: This study aims to determine complications, use, and duration of FTs placed during RBS.
SETTING: A high-volume academic medical center in the United States.
METHODS: Included patients underwent RBS between January 2008 and December 2016 with FTs placed at the time of RBS.
RESULTS: There were 126 patients identified (84.9% female, 76.2% Caucasian, mean age 53.4-±10.9 yr). Patients had previously undergone Roux-en-Y gastric bypass (34.1%), vertical banded gastroplasty (27.8%), and adjustable gastric band (14.3%). Indications for RBS included correction of complication of prior bariatric surgeries (50%), weight regain/failure to lose weight (32.3%), or both (17.3%). Most FTs were placed in the excluded stomach (89.7%), and median tube size was 18 F. FTs were used for feeding in 68.2% of patients, with feeding initiated in a median of 2 days. Leakage around the tube (32.5%) and pain (26.8%) were common complaints. Significant tube-related complications included infection (9.1%), dislodgement (5.9%), reintervention (5.8%), and reoperation (2.8%); 16.7% experienced at least 1 significant complication. FTs were removed at a median of 36 days.
CONCLUSION: FTs may aid in prevention of perioperative dehydration and malnutrition after RBS, but should not be considered a benign intervention. FT use should be balanced against institutional outcomes and care goals.
OBJECTIVES: This study aims to determine complications, use, and duration of FTs placed during RBS.
SETTING: A high-volume academic medical center in the United States.
METHODS: Included patients underwent RBS between January 2008 and December 2016 with FTs placed at the time of RBS.
RESULTS: There were 126 patients identified (84.9% female, 76.2% Caucasian, mean age 53.4-±10.9 yr). Patients had previously undergone Roux-en-Y gastric bypass (34.1%), vertical banded gastroplasty (27.8%), and adjustable gastric band (14.3%). Indications for RBS included correction of complication of prior bariatric surgeries (50%), weight regain/failure to lose weight (32.3%), or both (17.3%). Most FTs were placed in the excluded stomach (89.7%), and median tube size was 18 F. FTs were used for feeding in 68.2% of patients, with feeding initiated in a median of 2 days. Leakage around the tube (32.5%) and pain (26.8%) were common complaints. Significant tube-related complications included infection (9.1%), dislodgement (5.9%), reintervention (5.8%), and reoperation (2.8%); 16.7% experienced at least 1 significant complication. FTs were removed at a median of 36 days.
CONCLUSION: FTs may aid in prevention of perioperative dehydration and malnutrition after RBS, but should not be considered a benign intervention. FT use should be balanced against institutional outcomes and care goals.
Предметные рубрики MeSH
Academic Medical CentersAdultBariatric SurgeryBody Mass IndexCohort StudiesEnteral NutritionFemaleFollow-Up StudiesGastric BypassGastroplastyHospitals, High-VolumeHumansMaleMiddle AgedObesity, MorbidPostoperative ComplicationsReoperationRetrospective StudiesRisk AssessmentTime FactorsTreatment OutcomeUnited States